{{Rsnum
|rsid=1894292
|Gene=AFM
|Chromosome=4
|position=73483441
|Orientation=plus
|GMAF=0.3783
|Gene_s=AFM
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 33.6 | 40.7 | 25.7
| HCB | 9.5 | 43.1 | 47.4
| JPT | 13.3 | 44.2 | 42.5
| YRI | 9.5 | 42.9 | 47.6
| ASW | 15.8 | 49.1 | 35.1
| CHB | 9.5 | 43.1 | 47.4
| CHD | 15.6 | 50.5 | 33.9
| GIH | 36.6 | 44.6 | 18.8
| LWK | 10.0 | 49.1 | 40.9
| MEX | 8.6 | 48.3 | 43.1
| MKK | 9.0 | 46.2 | 44.9
| TSI | 21.6 | 46.1 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535732
  |Trait=Prostate cancer
  |Title=Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
  |RiskAllele=G
  |Pval=5E-13
  |OR=1.10
  |ORtxt=[1.06-1.12]
  |OA=1
}}

{{PMID Auto
|PMID=20015396
|Title=Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}